| Filed On | Filing |
|---|---|
| 27 Jun 2018 |
Form 3: Shire Human Genetic Therapies, Inc., 10% owner and 1 other · Translate Bio, Inc.
Holds 6,895,325 shares of Common Stock |
| 06 Aug 2003 |
Form 3: Shire Biochem Inc, 10% owner and 1 other · ImmunoGen, Inc.
Holds 4,096,098 shares of Common Stock |
| 08 Oct 2002 | Form 3 |
| 03 Aug 1999 | Form 3 |
Loading...
